Target Duration: 45 Minutes (approx. 30–35 slides to allow for Q&A) Audience: General Practitioners, General Gynecologists, Reproductive Endocrinologists & Infertility (REI) Specialists. [SLIDE GROUP 1: Introduction & The Diagnostic Shift (10 Mins) - Focus: GPs & Gynae] - Slide 1: Title Slide: Endometriosis and Adenomyosis in the Infertile Patient: A Unified, Evidence-Based Approach. - Slide 2: The Scale of the Problem: Prevalence in the infertile population (up to 50% in unexplained infertility). - Slide 3: Paradigm Shift: The New Diagnostic Criteria. Outline the major updates from ACOG Guideline No. 11—moving away from mandatory laparoscopy to valid clinical and advanced transvaginal ultrasound (TVUS) presumptive diagnosis. - Slide 4: Overlapping Pathologies: Endometriosis vs. Adenomyosis. Structural vs. extra-uterine definitions; why they must be evaluated together in fertility workups. [SLIDE GROUP 2: Mechanisms of Infertility (10 Mins) - Focus: All Specialists] - Slide 5: How Endometriosis Halts Conception: Pelvic anatomy distortion, chronic peritoneal inflammation, altered oocyte quality, and impaired tubal motility. - Slide 6: How Adenomyosis Sabotages Implantation: Myometrial hyperperistalsis, disrupted junctional zone (JZ), localized hyperestrogenism, and defective endometrial receptivity. - Slide 7: The "Dual Hit" on Embryo & Endometrium: Combining the poor oocyte quality of endometriosis with the hostile uterine environment of adenomyosis. [SLIDE GROUP 3: Advanced Non-Invasive Workup (10 Mins) - Focus: Gynae & REI] - Slide 8: Expert TVUS Systematics: Identifying the "soft markers" of endometriosis (sliding sign, fixed ovaries) and MUSA (Morphological Uterus Sonographic Assessment) criteria for adenomyosis (asymmetrical thickening, myometrial cysts). - Slide 9: The Role of Pelvic MRI: When ultrasound is inconclusive. Visualizing deep infiltrating endometriosis (DIE) and measuring Junctional Zone thickness (>12mm) to quantify adenomyosis severity. - Slide 10: Ovarian Reserve Mapping: The vital role of baseline AMH and AFC testing *before* any intervention is planned. [SLIDE GROUP 4: The Management Dilemma & Treatment Algorithms (15 Mins) - Focus: Gynae & REI] - Slide 11: Medical Management Limitations: Why suppressive therapies (GnRH agonists, progestins) treat pain but do not cure infertility in patients trying to conceive. - Slide 12: Surgical Intervention: When to operate vs. when to go straight to IVF. Balancing Endometrioma excision (cystectomy vs. ablation) against the risk of destroying the ovarian reserve. - Slide 13: ART Strategies: Downregulation protocols (Ultra-long GnRH agonist suppression for 2–3 months) before frozen embryo transfer (FET) to restore endometrial receptivity in adenomyosis. - Slide 14: Take-Home Algorithms: Step-by-step clinical pathway from GP suspicion to Specialist IVF referral.
Target Duration: 45 Minutes (approx. 30–35 slides to allow for Q&A)
Audience: General Practitioners, General Gynecologists, Reproductive Endocrinologists & Infertility (REI) Specialists.
[SLIDE GROUP 1: Introduction & The Diagnostic Shift (10 Mins) - Focus: GPs & Gynae]
- Slide 1: Title Slide: Endometriosis and Adenomyosis in the Infertile Patient: A Unified, Evidence-Based Approach.
- Slide 2: The Scale of the Problem: Prevalence in the infertile population (up to 50% in unexplained infertility).
- Slide 3: Paradigm Shift: The New Diagnostic Criteria. Outline the major updates from ACOG Guideline No. 11—moving away from mandatory laparoscopy to valid clinical and advanced transvaginal ultrasound (TVUS) presumptive diagnosis.
- Slide 4: Overlapping Pathologies: Endometriosis vs. Adenomyosis. Structural vs. extra-uterine definitions; why they must be evaluated together in fertility workups.
[SLIDE GROUP 2: Mechanisms of Infertility (10 Mins) - Focus: All Specialists]
- Slide 5: How Endometriosis Halts Conception: Pelvic anatomy distortion, chronic peritoneal inflammation, altered oocyte quality, and impaired tubal motility.
- Slide 6: How Adenomyosis Sabotages Implantation: Myometrial hyperperistalsis, disrupted junctional zone (JZ), localized hyperestrogenism, and defective endometrial receptivity.
- Slide 7: The "Dual Hit" on Embryo & Endometrium: Combining the poor oocyte quality of endometriosis with the hostile uterine environment of adenomyosis.
[SLIDE GROUP 3: Advanced Non-Invasive Workup (10 Mins) - Focus: Gynae & REI]
- Slide 8: Expert TVUS Systematics: Identifying the "soft markers" of endometriosis (sliding sign, fixed ovaries) and MUSA (Morphological Uterus Sonographic Assessment) criteria for adenomyosis (asymmetrical thickening, myometrial cysts).
- Slide 9: The Role of Pelvic MRI: When ultrasound is inconclusive. Visualizing deep infiltrating endometriosis (DIE) and measuring Junctional Zone thickness (>12mm) to quantify adenomyosis severity.
- Slide 10: Ovarian Reserve Mapping: The vital role of baseline AMH and AFC testing *before* any intervention is planned.
[SLIDE GROUP 4: The Management Dilemma & Treatment Algorithms (15 Mins) - Focus: Gynae & REI]
- Slide 11: Medical Management Limitations: Why suppressive therapies (GnRH agonists, progestins) treat pain but do not cure infertility in patients trying to conceive.
- Slide 12: Surgical Intervention: When to operate vs. when to go straight to IVF. Balancing Endometrioma excision (cystectomy vs. ablation) against the risk of destroying the ovarian reserve.
- Slide 13: ART Strategies: Downregulation protocols (Ultra-long GnRH agonist suppression for 2–3 months) before frozen embryo transfer (FET) to restore endometrial receptivity in adenomyosis.
- Slide 14: Take-Home Algorithms: Step-by-step clinical pathway from GP suspicion to Specialist IVF referral.
Created using ChatSlide
This overview addresses the evolving landscape of infertility diagnosis and management. It highlights the shift from invasive procedures to clinical diagnosis, particularly for conditions like endometriosis and adenomyosis. The focus is on understanding anatomical and inflammatory mechanisms through non-invasive techniques such as expert ultrasound and MRI. Management strategies are discussed, emphasising a balanced approach to treatment that considers ovarian reserve and the application of...